Browsing Tag
cancers
24 posts
Eli Lilly’s Strong Finish to 2023
Eli Lilly (LLY), one of the pharmaceutical giants, concluded 2023 on a high note, surpassing analyst expectations with…
Arcellx: A Promising Biotech Gem
In the dynamic world of biotechnology, identifying promising investment opportunities requires a keen eye for innovation and potential…
The Revolutionary Role of Generative AI in Healthcare: From Personalized Medicine to Novel Drug Discovery
While ChatGPT has undoubtedly proved its worth as a versatile and useful tool, the true measure of a…
Bluebird’s Gene Therapy for Sickle Cell Disease Faces FDA Hurdles
Bluebird (BLUE), a pioneering company in the field of gene therapy, has recently applied to the FDA for…
Pfizer’s Struggles and Potential Resurgence: A Deep Dive into FY24 Projections and Future Prospects
Pfizer (PFE), a pharmaceutical and biotech giant, is facing significant challenges as it grapples with ailing stock prices…
Unlocking the Potential of CRISPR: Samarth Kulkarni’s Insights on the First FDA Approved Treatment for Sickle Cell Disease
In a groundbreaking interview on CNBC, Samarth Kulkarni, the CEO of CRISPR Therapeutics, shared the remarkable journey of…
